Results 201 to 210 of about 246,840 (252)

Risk factors for vasculitis and vascular pain associated with cisplatin and vinorelbine in adjuvant chemotherapy. [PDF]

Pain Manag
Ishii S, Ichimura T, Ichikura D, Hida N, Nawata S.   +4 more
europepmc   +1 more source

Intravenous Lipopolysaccharide Challenge in Healthy Participants Reveals Pharmacodynamic Markers in Blood and Bone Marrow for Early‐Phase Oncology Drug Development

Clinical Pharmacology &Therapeutics, EarlyView.
Demonstrating pharmacological effects in early‐phase oncology clinical trials remains challenging, largely due to the lack of robust pharmacodynamic markers. Lipopolysaccharide (LPS) is used as an immune challenge agent in healthy participants to study drugs for autoimmune conditions.
Igor Radanović, Ingrid Tomljanović, Wieke H. Grievink, Diana R. Pereira, Michelle Osse, Peter van Balen, Maria J. Juachon, Marieke L. de Kam, Lisa Pagan, Manon A.A. Jansen, Matthijs Moerland, Jacobus J. Bosch   +11 more
wiley   +1 more source

Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02). [PDF]

Breast
Opdam M, Ultee N, Geenen JJJ, van Rossum AGJ, Mandjes IAM, Balduzzi S, Hofland I, Wesseling J, Menezes RX, Oosterkamp HM, Linn SC, MATADOR trialists' group for the Dutch Breast Cancer Research Group (BOOG).   +11 more
europepmc   +1 more source

Correction: Evaluation of PINK1 protein expression as a predictive marker for the efficacy of adjuvant chemotherapy in colorectal cancer: a retrospective study. [PDF]

BMC Gastroenterol
Fujii T, Hirasaki M, Kamakura Y, Kawasaki T, Yamasaki S, Ishiyama Y, Hiranuma C, Hamaguchi T, Hirano Y, Sakuramoto S.   +9 more
europepmc   +1 more source

Grade-driven adjuvant chemotherapy benefit in high-risk stage IB NSCLC: a retrospective cohort study. [PDF]

J Thorac Dis
Tao H, Lu S, Zhu X, Cong Z, Luo J, Du H, Liu C, Wu H, Shen Y.   +8 more
europepmc   +1 more source

Thymic rebound after adjuvant chemotherapy in breast cancer: a case report. [PDF]

Future Sci OA
Ayari M, Ben Azouz S, Chehaider A, Ben Rejeb S, Jomni T.   +4 more
europepmc   +1 more source

Survival benefit of adjuvant chemotherapy for duodenal adenocarcinoma: a retrospective cohort study and propensity score-matched analysis. [PDF]

Transl Cancer Res
Luo Y, Fan Y, Fan C, Chen Z, Fan Y, You Z, Ye X.   +6 more
europepmc   +1 more source

What is the adherence to an exercise intervention during (neo-)adjuvant chemotherapy among Swedish patients with breast cancer? Data from the Phys-Can randomised controlled trial. [PDF]

BMJ Open
Henriksson A, Stenling A, Mazzoni AS, Sjövall K, Börjeson S, Berntsen S, Bean CG, Buffart LM, Nordin K, Demmelmaier I.   +9 more
europepmc   +1 more source

Mesenchymal Chondrosarcoma Presenting as Atypical Brown–Sequard Syndrome

Annals of the Child Neurology Society, EarlyView.
Naman D. Shah, Adam Z. Kalawi, Rachel Pearson, Ali Nael, John R. Crawford   +4 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Surgical Adjuvant Chemotherapy

Annual Review of Medicine, 1977
The evidence that the principles of surgical adjuvant chemotherapy developed in experimental animal systems also apply to a variety of neoplastic diseases in man has been clearly demonstrated. Micrometastatic disease can be eradicated with effective chemotherapy in several diseases. Prolongation of disease-free interval, if not cure, is now possible in
M, Perloff, J F, Holland
openaire   +2 more sources